Trials have demonstrated that individuals with prior myocardial infarction (MI), type 2 diabetes mellitus, or multiple cardiovascular disease (CVD) risk factors who received advice on the Mediterranean dietary pattern and supplemental high monounsaturated fat foods have lower rates of CVD than control groups. 5, 6 Mediterranean-style dietary patterns have been associated with lower rates of coronary heart disease (CHD), 7, 8 sudden cardiac death, 9 and CVD mortality, 10 lower blood pressure 11 and inflammatory markers, 11, 12 and better endothelial, 12 left ventricular, 13 and cardiac autonomic function. 14 The DASH dietary pattern effectively reduced blood pressure in trials. 15, 16 In a single arm study, patients with HF had lower blood pressure, arterial stiffness, and oxidative stress after 3 weeks of the DASH dietary pattern. 17 Observational studies suggest that consistency with DASH may reduce the risk of developing HF 18 and CHD. 19, 20 To explore the relationship of dietary patterns with mortality among women with HF, we evaluated the associations of Mediterranean and DASH diet scores with mortality among Women's Health Initiative (WHI) participants after hospitalization for HF.
Methods

Study Population
The WHI has previously been described. 21, 22 Between 1993 and 1998, postmenopausal women aged 50 to 79 years were recruited at 40 US clinical centers. During the WHI CT and OS (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) , HF hospitalizations were adjudicated locally, with central adjudication for quality control. Adjudication of HF hospitalization was based on ≥1 of the following criteria: (1) diagnosis by a physician and receipt of medical treatment for HF during admission including diuretics, digitalis, vasodilators, and angiotensin-converting enzyme inhibitors; (2) HF diagnosed by a physician and receipt of medical treatment for HF during admission plus documented impaired systolic or diastolic left ventricular function; (3) pulmonary edema or congestion by chest radiographs on admission; or (4) dilated ventricles or poor left-or right-side ventricular function (eg, wall motion abnormalities) by echocardiography, radionuclide ventriculogram/multigated acquisition, or other contrast ventriculography or evidence of left ventricular diastolic dysfunction. 23 HF hospitalizations were not adjudicated during the WHI ES. We identified 4043 WHI CT and OS participants who had a HF hospitalization between study entry and 2005 ( Figure I in the online-only Data Supplement). We excluded 29 participants who did not survive ≥1 day past HF hospitalization, 605 participants missing information on dietary intake or covariates, and 194 participants with implausible energy intake (<600 or >5000 kcal/d) calculated using a food-frequency questionnaire (FFQ), producing a final sample size of 3215 women (Table I in the online-only Data Supplement). Women who did not survive HF hospitalization were excluded because the outcome of interest was posthospitalization mortality. Women with calculated energy intake <600 or >5000 kcal/d were excluded in accordance with the WHI analytic guidelines because the extreme energy intake suggests that the FFQ was not reliable. The WHI was approved by institutional review boards at all participating centers and the Clinical Coordinating Center, and written informed consent was obtained from all participants.
Dietary Intake Measurement
Dietary intake was assessed using a modified Block FFQ. 24 The FFQ was administered during a baseline screening visit for all participants.
Subsequently, all participants in the DM trial completed FFQs at year 1, a proportion of the DM participants completed FFQs yearly thereafter, and OS participants completed FFQs at year 3. We selected the most recently completed FFQ before HF hospitalization for each participant. The FFQs were completed a median of 2.3 (interquartile range, 1.2-3.8) years before HF hospitalization. We calculated Mediterranean and DASH diet scores as previously described. 7, 20 Total energy intake was calculated using calibration equations derived from doubly labeled water studies. 25 Details are reported in Methods in the online-only Data Supplement.
Covariates
Covariates were assessed by questionnaires, pill-bottle reviews, and measurement of blood pressure, height, and weight. The most recent assessment of covariates before HF hospitalization was selected for each individual. Information on personal habits, such as smoking, was recorded at a median of 2.5 (interquartile range, 1.2-5.0) years before HF hospitalization. Women were considered to have comorbidities, such as MI or revascularization, if they reported a history of the condition at the time of WHI enrollment or if they experienced the condition during WHI follow-up before HF hospitalization.
Mortality Follow-Up
Follow-up for mortality was conducted as part of the WHI OS, CT, and ES. For this study, follow-up began on the date of HF hospitalization and continued through the date of death or the last contact with the participant before August 2009. Deaths were ascertained through direct reports to the WHI by participants' family, friends, or healthcare providers; response to WHI mailings by participants' family, friends, or the US Postal Service; Internet searches, including searches of obituaries; the Social Security Death Index; and the National Death Index. 26 Deaths classified as definite CHD, possible CHD, cerebrovascular, other cardiovascular, and unknown cardiovascular were considered CVD deaths.
Statistical Analysis
We summarized participant characteristics using mean and SDs for continuous variables and percentages for categorical variables. We tested for differences in characteristics by mortality status using linear regression for continuous variables and χ 2 tests for categorical variables. We classified the participants by approximate quartile of diet score (groups had unequal numbers of participants because of the large number of ties in diet scores). Mean intake of food groups and nutrients was calculated within quartile of the diet scores. Tests of trend across category were conducted using linear regression models with the median value of the diet score in each quartile as the predictor. We calculated a Spearman correlation coefficient between the Mediterranean and DASH diet scores.
Cox proportional hazards models were used to estimate the hazard ratios of mortality associated with quartiles of the DASH and Mediterranean diet scores. To account for variability appropriately in the calibrated total energy estimate, we calculated SEs for the regression coefficients using bootstrap resampling, which were then used to calculate P values and 95% confidence intervals as previously described. 25 To accommodate the bootstrap procedure, we excluded individuals missing data (ie, a complete case analysis) instead of using multiple imputation. Model 1 adjusted for age at HF hospitalization (linear) and total energy intake (linear). Model 2 further adjusted for race/ethnicity (white, black, or other), education (less than high school, high school graduate including some college, college graduate, or graduate school), income (<$20 000, $20 000-34 999, $35 000-49 999, or ≥$50 000), married (yes or no), current smoking (yes or no), total exercise (metabolic equivalent hour/wk, linear), physical function score (linear), use of off-study postmenopausal hormone therapy, and WHI study arm. In model 3, we further adjusted for variables which may have been intermediates or confounders of the association of the dietary scores with mortality, including systolic blood pressure (linear), diastolic blood pressure (linear), use of diuretics, β-blockers, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, body mass index (linear), and history of high cholesterol, high blood pressure, diabetes mellitus, MI, coronary revascularization, and atrial fibrillation. Tests for linear trend across quartiles of the diet score were performed by including the median value in each quartile as a continuous variable in the models. In addition, we calculated the hazard ratio for a 1-U difference in the diet scores. We examined potential nonlinearity by including the square of the diet scores in the models.
In sensitivity analyses, we examined the associations between diet scores and mortality in the subgroup who did not report a history of HF at study entry because pre-existing HF may alter dietary intake (n=2922), the subgroup without a history of cancer at baseline or during follow-up because of the cardiotoxic effects of some chemotherapeutic agents (n=2583), the subgroup limited to those with a physician diagnosis of HF at the index hospitalization because of the potential for misclassification of disease in those without a physician diagnosis of HF (n=2955), and the subgroup who were not in the DM or CaD trials because DM and CaD participants may have altered their dietary intake in ways not captured by the FFQ (n=2039). We examined the associations of Mediterranean and DASH diet scores with CVD mortality and in subgroups defined by body mass index, history of diabetes mellitus, history of MI or revascularization, income, and cigarette smoking. Tests of whether the associations varied across subgroups were performed by entering interaction terms between indicators of subgroup membership and the median diet score in each quartile into the models. We examined the association of the components of the Mediterranean and DASH diet scores with mortality using Cox proportional hazards models adjusted as in model 3 above. Because 60% of this population did not drink sweetened beverages, we examined intake in 3 rather than 4 categories for this component.
We tested the proportional hazards assumption by including the product of diet scores and the natural logarithm of time as a term in the models; there was no evidence of violation of this assumption. Statistical analyses were conducted using SAS version 9.3 (SAS Institute, Inc, Cary, NC). Two-sided P values <0.05 were considered statistically significant. No adjustments were made for multiple comparisons.
Results
For a median of 4.6 years of follow-up, 1385 of 3215 (43.1%) WHI participants who experienced a HF hospitalization died; 694 deaths were because of CVD (Table II in the online-only Data Supplement). Women who died were, on average, older, lower income, less likely to be married, more likely to smoke cigarettes, less physically active, and had slightly lower body mass index, and were more likely to have a history of high cholesterol, diabetes mellitus, MI, revascularization, and atrial fibrillation (Table 1) . Women in higher quartiles of the Mediterranean and DASH diet scores had higher average intake of fruit, vegetables, nuts, legumes, whole grains, low-fat dairy, fish, and lower intake of red and processed meats and sweetened beverages (Table III in the online-only Data Supplement) when compared with women in the lower quartiles. Protein, carbohydrate, potassium, calcium, magnesium, and fiber were higher in the upper quartile of the diet scores and saturated, monounsaturated, and polyunsaturated fat were lower. Sodium intake was positively associated with the Mediterranean diet score and inversely associated with the DASH diet score. Women in the higher quartiles of the diet scores had higher alcohol consumption. The correlation between Mediterranean and DASH diet scores was 0.67.
Higher Mediterranean diet score was associated with a lower hazard rate of death among women with HF in the ageand energy-adjusted model (Table 2) . After adjustment for demographics, health behaviors, comorbidities, and medications, women with Mediterranean diet scores in the top quartile had a 15% lower hazard rate of death than those in the bottom quartile although the test of trend was not statistically significant (P=0.08). In the fully adjusted models, the hazard ratio associated with a 1-U higher Mediterranean diet score was 0.97 (95% confidence interval, 0.93-1.00; P=0.06). We did not find evidence for a nonlinear association (P for test of quadratic trend=0.63).
Women with a higher DASH diet score had a lower hazard rate of death in models adjusted for age and energy intake and in more extensively adjusted models. In multivariable-adjusted models, women with HF who had DASH diet score in the top quartile had a 16% lower hazard rate of death than women with scores in the bottom quartile (P for linear trend=0.01). In the fully adjusted models, the hazard ratio associated with a 1-U higher DASH diet score was 0.98 (95% confidence interval, 0.97-0.99; P=0.003). We did not find evidence for a nonlinear association (P for test of quadratic trend=0.29).
Results were consistent in sensitivity analyses in subgroups of women without self-reported HF at baseline, women without cancer, and women who had physician diagnosis of HF at the index hospitalization (Table IV in the online-only Data Supplement). The associations were also consistent when we excluded women in the DM and CaD trials. Women in the top quartiles of the Mediterranean and DASH diet scores had a 12% and 18% lower hazard rate, respectively, of CVD mortality then women in the bottom quartiles, but the associations were not statistically significant (Table V in the online-only Data Supplement). There was no statistically significant variation in the associations of Mediterranean or DASH diet scores with mortality across strata of body mass index, history of diabetes mellitus, history of CHD, income, or smoking status (Table VI in the online-only Data Supplement). Vegetables, nuts or nuts and legumes, and whole grains were inversely associated with mortality after HF (Table 3) . Other components of the diet scores did not seem to be associated with mortality.
Discussion
In this population with HF, women in the top quartile of the DASH diet score had a 16% lower hazard rate of death than those in the bottom quartile (P for linear trend=0.01). The association of the Mediterranean diet score with mortality was not statistically significant (P for linear trend=0.08), but there was a trend toward lower hazard of mortality with higher Mediterranean diet score. These results suggest that dietary patterns recommended for the general population may also be beneficial in people with HF. Currently, few patients with HF meet general nutritional recommendations. [27] [28] [29] Trials of controlled diets or dietary counseling among patients with HF are needed to determine conclusively whether Mediterranean or DASH dietary patterns reduce mortality.
Both the Mediterranean and DASH dietary patterns can improve cardiovascular health. In trials with controlled diets, the DASH dietary pattern produced a substantial decrease in blood pressure, 15, 16 reduced total and low-density lipoprotein cholesterol, 30 and decreased markers of inflammation, liver dysfunction, and coagulation abnormalities. 31 In addition, in observational studies, higher DASH diet scores were associated with lower rates of incident CHD 19, 20 and HF. 18 In a single arm study of patients with HF and preserved ejection fraction, 3 weeks of the DASH dietary pattern resulted in lower blood pressure, arterial stiffness, and oxidative stress. 17 Advice to follow the Mediterranean dietary pattern combined with provision supplemental extra virgin olive oil or nuts reduced first CVD events as compared with advice to follow a low-fat diet in high-risk individuals with type 2 diabetes mellitus or multiple risk factors for CVD in the PREDIMED (Prevencion con Dieta Mediterranea) randomized trial. 5 Post-MI patients in the Lyon Heart Study who were randomized to receive advice on following a Mediterranean dietary pattern had a lower rate of CVD mortality and nonfatal MI than the control group who did not receive specific dietary advice. 6 Higher Mediterranean diet scores have been associated with lower rates of CVD and better CVD risk profiles. [7] [8] [9] [10] [11] [12] 14 In patients with HF, the Mediterranean diet score was associated with better systolic and diastolic function. 32 The Alternative Healthy Eating Index and the WHI Dietary Modification Index, including some of the same components as the Mediterranean and DASH scores, were inversely associated with incident HF in the WHI population. 33 Dietary patterns are complex mixtures of foods and nutrients, and benefits may represent effects of specific foods or nutrients, interactions between foods and nutrients, displacement of other foods and nutrients, or combinations of these mechanisms. The aspect or aspects of the Mediterranean or DASH dietary patterns which affect CVD have not yet been determined. In this study, higher intake of vegetables, nuts and legumes, and whole grains were associated with lower mortality rates, but other dietary components including sodium and alcohol were not. In a prior study of patients with HF, intake of sodium was positively associated with mortality and acute decompensation. 34 However, FFQs such as the one used in this study are not well-suited for capturing sodium intake 35 as sodium was not a targeted nutrient for assessment. Other nutrients correlated with, but not included in, the diet scores such as magnesium, potassium, and calcium may also contribute to the associations. However, magnesium, potassium, and calcium intake were not associated with mortality in this population. 36 Although identifying specific nutrients which could prolong life among people with HF is of scientific interest, for patients, dietary advice focused on foods may be more relevant.
The racially and ethnically diverse study population, extensive covariate information available, large number of adjudicated HF hospitalizations, and relatively long followup for post-HF hospitalization mortality are strengths of this study. There are also limitations. HF is a progressive clinical syndrome with heterogeneous pathogenesis and anatomic and physiological disturbances. The effect of dietary patterns ‡Adjusted for variables in model 2 and systolic blood pressure, diastolic blood pressure, use of diuretics, β-blockers, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, body mass index, and history of high cholesterol, high blood pressure, diabetes mellitus, myocardial infarction, coronary revascularization, and atrial fibrillation. may vary across HF subtypes and disease severity. Neither HF pathogenesis nor severity was available in this population. However, HF hospitalization was an entry criterion in this study, excluding individuals with mild HF treated exclusively on an outpatient basis. FFQs are known to have substantial errors. Sodium and fluid intake, which are thought to be important in patients with HF, were not targeted in the design of the FFQ. We were not able to study intake of olive oil specifically, a characteristic of the Mediterranean dietary pattern, because it was not distinguished from other cooking oils with high monounsaturated fat content in the FFQ. We used dietary assessments made before HF hospitalization, and we have not detected possible changes in dietary intake or adherence to sodium or fluid restriction after HF hospitalization. This could lead to misclassification of dietary intake during the relevant time period. We used previous described Mediterranean and DASH diet scores calculated from the FFQs, which may not fully capture the dietary patterns. 12, 20 In particular, the Mediterranean diet score has a small range (0-9 points), and more than half of this population had scores of 3, 4, or 5 suggesting that it may not be able to distinguish between individuals with different patterns of dietary intake. This may partially explain why the association of the Mediterranean diet score did not reach statistical significance, despite the large number of deaths. In addition, we were not able to rule out unmeasured or residual confounding, for example, by severity of HF or comorbidities or by the trial interventions.
In summary, higher DASH diet scores were modestly associated with lower mortality in women with HF; there was a trend toward an association with the Mediterranean diet score that did not reach statistical significance. These data provide support for the idea that diet recommendations developed for the general population or those with other cardiovascular conditions may also be appropriate for patients with HF. Randomized trials of diets including fruits, vegetables, whole grains, nuts, and legumes and low in processed foods and red meats in patients with HF are warranted. *Hazard ratios and 95% confidence intervals adjusted for age at heart failure hospitalization, total energy intake, race/ethnicity, education, income, married, current smoking, total exercise, physical function, use of off-study postmenopausal hormone therapy, Women's Health Initiative (WHI) study arm, systolic blood pressure, diastolic blood pressure, use of diuretics, β-blockers, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, body mass index, and history of high cholesterol, high blood pressure, diabetes mellitus, myocardial infarction, coronary revascularization, and atrial fibrillation.
†Divided into tertiles because of limited range of intake.
